IRIS
PORTA, CAMILLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.319
EU - Europa 1.888
AS - Asia 1.554
AF - Africa 12
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.284
CN - Cina 1.537
IE - Irlanda 1.167
FI - Finlandia 251
DE - Germania 129
UA - Ucraina 114
IT - Italia 85
SE - Svezia 81
CA - Canada 35
GB - Regno Unito 19
FR - Francia 16
MU - Mauritius 11
NL - Olanda 8
BE - Belgio 7
IN - India 5
RU - Federazione Russa 5
AU - Australia 4
JP - Giappone 4
BR - Brasile 2
EU - Europa 2
GR - Grecia 2
IR - Iran 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
KZ - Kazakistan 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
SG - Singapore 1
Totale 6.784
Salva come PNG Salva come JPEG
Città #
Dublin 1.167
Chandler 870
Nanjing 380
Beijing 334
Ashburn 319
Princeton 230
Lawrence 221
Helsinki 167
Jacksonville 167
Medford 167
Wilmington 165
Nanchang 157
Jiaxing 102
Changsha 91
Hebei 91
Shenyang 90
Hangzhou 88
Ann Arbor 64
Shanghai 56
New York 54
Tianjin 48
Dearborn 39
Norwalk 36
Pavia 36
Toronto 29
Boardman 23
Fairfield 23
Los Angeles 23
Woodbridge 19
Washington 18
Redwood City 17
Jinan 13
Guangzhou 12
Ningbo 12
Seattle 10
Zhengzhou 10
Des Moines 9
Kunming 9
Taizhou 9
Atlanta 7
Brussels 7
Milan 6
Verona 6
Berlin 4
Borås 4
Meppel 4
Rockville 4
Sacramento 4
San Genesio Ed Uniti 4
Falkenstein 3
Fuzhou 3
Hefei 3
Honcho 3
San Francisco 3
Serra 3
Tappahannock 3
Cambridge 2
Canberra 2
Cedar Knolls 2
Chengdu 2
Groningen 2
Leawood 2
Monmouth Junction 2
Ottawa 2
Pognana Lario 2
Pune 2
Redmond 2
Walnut 2
Andover 1
Arapiraca 1
Ardabil 1
Belgrade 1
Brisbane 1
Budapest 1
Cairo 1
Changchun 1
Frankfurt am Main 1
Fremont 1
Gijón 1
Gunzenhausen 1
Haikou 1
Hawthorne 1
Jaipur 1
Kashan 1
Lanzhou 1
Las Vegas 1
Maratea 1
Melbourne 1
Nogara 1
Novokuznetsk 1
Nuremberg 1
Orange 1
Pinehaven 1
Qingdao 1
Saint Petersburg 1
Shijiazhuang 1
Sungai Besar 1
São Paulo 1
Tomsk 1
Torino 1
Totale 5.502
Salva come PNG Salva come JPEG
Nome #
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study. 75
Antiproliferative and cytokinetic effects of the specific Akt inhibitor perifosine on different solid tumor cell lines. 71
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells. 71
Analysis of TERRA expression in Head and Neck Tumors. 69
Orai1 and Transient Receptor Potential channels as novel molecular targets to impair tumor neovascularisation in renal cell carcinoma and other malignancies 67
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 67
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 66
Autoimmunity in thrombotic thrombocytopenic purpura 65
Analysis of TERRA expression in Head and Neck Tumors. 65
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella 64
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study 64
Cytokinetic and pro-apoptotic effects induced by inhibition of Aurora Kinases: a novel strategy for malignant mesothelioma treatment. 62
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 62
Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes 62
Lingual metastasis from renal cell carcinoma: a case report and literature review. 61
Endoplasmic reticulum Ca2+ handling and apoptotic resistance in tumor-derived endothelial colony forming cells 61
Acute Kidney Injury in Cancer Patients 61
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system 58
Ultrastructural and functional differences between normal and tumor endothelial progenitor cells 57
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 57
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients. 55
[Hypokalemic rhabdomyolysis and thiazide diuretics. 3 clinical cases] 53
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 52
Circulating endothelial progenitor cells from patients with renal cell carcinoma display aberrant VEGF regulation, reduced apoptosis and altered ultrastructure 50
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. 50
[Eosinophilic infiltration of the gastrointestinal system: description of a clinical case simulating a lymphoproliferative process] 50
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib 50
Autoantibody Profile In Thrombotic Thrombocytopenic Purpura 49
Eosinophils and C4 predict clinical failure of combination imunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 49
Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation? 48
Thrombotic Thrombocytopenic Purpura In Systemic Lupus-erythematosus 47
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy 47
Phenotypic and functional characterization of endothelial progenitor cells isolated from peripheral blood of renal cell carcinoma patients 47
Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients 46
Nephrectomy As A Component of Systemic Treatment For Renal-cell Carcinoma Patients 46
Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis 46
Sarcoidosis following beta-interferon therapy for multiple myeloma 45
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from tumoral patients; its role in cell proliferation and tubulogenesis 44
Concurrent intra-arterial carboplatin administration and radiation therapy for the tretment of advanced head and neck squamous cell carcinima: short term results. 43
Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTP 43
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis? 43
Telomeric repeat-containing RNAs (TERRA) decrease in squamous cell carcinoma of the head and neck is associated with worsened clinical outcome 42
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 42
Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Italian Cooperative Group for TTP 41
Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: A preliminary report 41
Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? the experience of Italian centers 41
Inhibition of Aurora kinases as a novel strategy to treat malignant mesothelioma (Mme): cytokinetic and pro-apoptotic effects.. 40
Hypocholesterolemia and acute myeloid leukemia (AML) 40
Anti-HCV antibodies and hepatocellular carcinoma. Relationship in a medium-risk population 40
Apoptosis and cell cycle status of hematopoietic progenitor cells in patients with severe refractory rheumatoid arthritis candidates to autografting 39
Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model 39
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma 39
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from patients suffering of Renal Cellular Carcinoma. 39
Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient 39
Ocular involvement in acute thrombotic thrombocytopenic purpura 39
Verapamil inhibits to different extents agonist-induced Ca2+ transients in human tumor cells and in vitro tumor cell growth 39
Atrial septal aneurysm in a patient with pseudoxanthoma elasticum 39
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study 39
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 39
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 38
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 38
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation 38
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation 37
5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer 37
Colon cancer in pregnancy: report of a case and review of the literature 37
Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects 37
Osteonecrosis of the Jaw in Patients with Metastatic Renal Cell Cancer Treated with Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature 37
Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer 37
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA 36
Oxidative stress reduces transintestinal transports and (Na(+), K(+))-ATPase activity in rat jejunum. 36
Plasma and urinary endothelin-1 titers and plasma von Willebrand activity in Pseudoxanthoma elasticum 36
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas 36
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 36
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity? 36
Clinical impact of Pancreatic metastases from renal cell carcinoma: A multicenter retrospective analysis 36
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma 36
Increased serum lipase with associated normoamylasemia in cancer patients 36
Chronic Epstein-Barr virus infection 36
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. 35
Renal effects of targeted anticancer therapies 35
Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients 35
5-Fluorouracil combined with the pure L-stereoisomer of leukovorin calcium to treat advanced colon-cancer patients - a phase-ii study 35
Low doses of alpha 2B interferon in the treatment of hairy cell leukemia: results of treatment and mean follow-up at 18 months in 13 patients 35
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma 35
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma] 35
Platelet agonists and calcium homeostasis in endothelial cells: possible role in the interaction of endothelium with hemostatic system 35
null 34
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 34
Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity 34
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 34
Targeted therapy for renal cell carcinoma: Focus on 2nd and 3rd line 34
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 34
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 33
Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects 32
The intracellular Ca2+ toolkit regulates VEGF-mediated gene expression in normal, but not tumoral, human circulating endothelial progenitor cells. 32
Autoimmunity in thrombotic thrombocytopenic purpura 32
[The infusion of high-dose immunoglobulins in a case of idiopathic thrombocytopenic purpura] 32
Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism 32
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis 32
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 32
Totale 4.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 16 18 7
2019/20201.792 440 711 20 22 2 29 122 73 13 150 200 10
2020/2021323 29 15 12 20 7 35 11 96 14 41 29 14
2021/2022836 9 2 35 8 18 11 8 56 47 23 152 467
2022/20232.824 363 212 47 175 187 236 1 134 1.350 15 72 32
2023/2024920 136 189 36 60 92 286 16 58 7 40 0 0
Totale 7.062